![](https://webarchive.library.unt.edu/eot2008/20081025110112im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081025110112im_/http://www.cancer.gov/images/spacer.gif)
autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine A cell-based vaccine composed of autologous dendritic cells (DCs) pulsed with lysates from heat-treated allogeneic melanoma tumor cells. Upon administration, this vaccine may stimulate anti-tumoral cytotoxic T-cell and antibody responses to melanoma cells bearing shared melanoma antigens such as MelanA/MART-1, gp100, MAGE3, resulting in tumor cell lysis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20081025110112im_/http://www.cancer.gov/images/spacer.gif)
Synonym: | ![](https://webarchive.library.unt.edu/eot2008/20081025110112im_/http://www.cancer.gov/images/spacer.gif) | Allogeneic Melanoma Cell-Loaded Dendritic Cell Vaccine | | ![](https://webarchive.library.unt.edu/eot2008/20081025110112im_/http://www.cancer.gov/images/spacer.gif) | US brand name: | ![](https://webarchive.library.unt.edu/eot2008/20081025110112im_/http://www.cancer.gov/images/spacer.gif) | Uvidem | | ![](https://webarchive.library.unt.edu/eot2008/20081025110112im_/http://www.cancer.gov/images/spacer.gif) | Code name: | ![](https://webarchive.library.unt.edu/eot2008/20081025110112im_/http://www.cancer.gov/images/spacer.gif) | IDD-3 | | ![](https://webarchive.library.unt.edu/eot2008/20081025110112im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081025110112im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081025110112im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081025110112im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081025110112im_/http://www.cancer.gov/images/spacer.gif) |